Lower ratings of pain intensity in older adults lead to underestimation of disease activity in patients with rheumatoid arthritis
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 2
Abstract
Background: To investigate the influence of age on the components of the 28-joint Disease Activity Score (DAS28)-C-Reactive Protein (CRP) in patients with Rheumatoid Arthritis (RA) and whether DAS28-CRP can be equally interpreted in all age groups. Methods: The proportion of CRP and patient reported components of the DAS28 (DAS-P) were analyzed and compared between 2 age groups (younger RA <60, older RA ≥ 60) using Mann-Whitney U test. Inflammatory disease burden in the joint was calculated by modified DAS28 (MDAS28=0.49 x ln(C-Reactive Protein (CRP))+0.15 x swollen joint count 28+0.22 x physician global assessment (PhGA)+1). Multivariate analyses were used to design models best predicting the effect of age on CRP, the proportion of CRP, inflammation level calculated by MDAS28, DAS-P, and pain levels. Results: CRP and the proportion of CRP in DAS28-CRP were not influenced by age. MDAS28 did not increase with age but was associated with disease duration and anti-tumor necrosis factor (TNF) therapy. DAS-P and pain level had significant negative association with age. In subjects with moderate inflammation (defined by MDAS28 score above 50 percentile, N=370), older RA subjects (N=189) had lower pain level, tender joint count, patient and physician global assessment, DAS28-CRP than younger subjects (n=157). Conclusions: CRP, proportion of CRP in DAS28-CRP, and MDAS28 were not influenced by age but the proportion of subjective components of DAS28-CRP and pain level decreased with age. Therefore, disease activity could be underestimated by DAS28-CRP in older RA patients.
Authors and Affiliations
Yong Gil Hwang, Ajay D Wasan, June Feng, Heather Eng, Jason Lyons, Anthony Fabio, Larry W Moreland
Keywords
Related Articles
- EP ID EP603276
- DOI -
- Views 58
- Downloads 0
Nanomedicine in rheumatology: A new field in the diagnosis and therapy of rheumatic diseases
Nanomedicine is a prolific and vastly expanding field of medicine rendering important new avenues to improve diagnosis and treatment of human maladies. However, safety of the nanomaterials and therapeutic agents must be...
Rheumatic and musculoskeletal manifestations in renal hemodialysis patients
Objectives: To determine the frequency of Rheumatic and Musculoskeletal Diseases (RMDs) in patients with renal failure on regular hemodialysis. Methods and findings: The present study included forty-nine patients (28 ma...
Predictive value of rheumatoid factor titre in cryoglobulinemia in Hepatitis C positive patients
Background/objective: HCV viremia has been known to provoke a plethora of autoimmune syndromes as well as nonspecific rheumatologic manifestations. HCV is the most frequent cause of mixed cryoglobulinemia, which is chara...
Refractory thrombocytopenia in SLE patient with massive thigh hematoma and hematuria successfully treated with Rituximab: Case Report
Background: Systemic Lupus Erythematosus is a multisystemic inflammatory disease with broad clinical presentation, 9.5% to 44.5% of patients with SLE have thrombocytopenia complication of different grades. No significant...
Small fiber neuropathy as a part of fibromyalgia or a separate diagnosis?
Fibromyalgia (FM) is a chronic disease characterized mainly by widespread pain, fatigue and cognitive disorders. Small Fiber Neuropathy (SFN) is a generalized sensory nerve disorder with structural and functional nerve a...